Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

BACKGROUND: Mantle cell lymphoma (MCL) is a B cell malignancy that can be aggressive and with a poor prognosis; the clinical course is heterogeneous. The epidemiology of MCL in Asia is not well documented but appears to comprise 2–6% of all lymphoma cases based on available data, with variation obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079508/
https://www.ncbi.nlm.nih.gov/pubmed/32183871
http://dx.doi.org/10.1186/s13045-020-00855-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079508/
https://www.ncbi.nlm.nih.gov/pubmed/32183871
http://dx.doi.org/10.1186/s13045-020-00855-9

Ejemplares similares